newsfilter
← Latest News
Business Wire·

Pear Therapeutics Announces Process Exploring Strategic Alternatives

Pear Therapeutics, Inc. (NASDAQ:PEAR) ("the Company"), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it is engaged in a